Federal Reserve Loses Impetus for Rate Cuts as Jobs Data Signals Persistent Inflation Bloom Energy Surges After 26 Billion Partnership with European AI Data Center Firm Nebius SpaceX Files for IPO Under Ticker SPCX Potentially Boosting Elon Musks Wealth to Trillionaire Status BitMine Emerges as Candidate for Russell 1000 Index Inclusion Spains Youth Housing Crisis Rent Absorbs 987 of Wages Emancipation Plummets to Record Low Trump Dismisses Concerns Over Powells Continued Tenure at Federal Reserve CGON Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment JAGX Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges LOAR Q1 2026 Earnings Massive EPS Beat Signals Strong Execution Revenue Data Not Reported ACIW Q1 2026 Earnings Earnings Beat on Strong EPS Surprise Stock Edges Lower AA Q1 2026 Earnings EPS Misses Estimates Shares Rise Amid Operational Resilience LNZA Q4 2025 Earnings Loss Narrower Than Expected Shares Slide Manchester United Shares Slip Amid Performance Concerns Dawson Geophysical DWSN Tests Support Amid Continued Selling Pressure Brookfield Infrastructure Partners BIP Edges Lower in Quiet Session Key Levels to Watch Cardlytics CDLX Inches Up as Key Support Holds A Closer Look at the Recovery Align Technology ALGN Surges 64 Breaking Out of Support Zone US and Iran Signal Potential Progress but Remain at Odds Over Key Issues EH Q4 2025 Earnings Massive EPS Beat Drives Positive Surprise Despite Revenue Absence Lincoln Educational Services LINC Surges 33 as Shares Approach Key Resistance Zone Community Healthcare Trust CHCT Q1 2026 Earnings Massive EPS Beat Masks Continued Market Caution FBIN Q1 2026 Earnings Narrow EPS Miss on Flat Revenue as Stock Advances WTTR Q1 2026 Earnings Earnings Per Share Soars Past Estimates with 106 Surprise NHI Q1 2026 Earnings EPS Falls Short of Estimates Amid Stable Operations Medline Inc MDLN Q1 2026 Earnings EPS Surpasses Estimates by 949 Amidst Limited Revenue Disclosure Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress TCRT Q4 2023 Earnings EPS Miss as PreRevenue Biotech Reports Operational Progress